Hal Barron

Type: Person
Name: Hal Barron
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Jason Rhodes joins Atlas Venture investing team

Atlas VentureJason Rhodes joined the investing team.Biotech> NewLink Genetics ( $NLNK ) has appointed Jack Henneman as executive vice president and chief financial officer. Release> Bio-Rad Laboratories ($BIO) has appointed John Goetz as chief operating ... [Published FierceBiotech - Oct 03 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

BioNews [10.1.14]

Top News HeadlineCompanyType Portola's 'breakthrough' anti-anticoagulant clears a Phase III hurdle Portola PharmaceuticalsStudy Results FDA Slaps Valeant With A Warning Letter Valeant PharmaceuticalsWarning Letter OnCore Biopharma Agrees ... [Published eClinical Trends - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Juno Therapeutics Appoints M.D. To Board Of Directors

) – Juno Therapeutics, Inc. today announced the appointment of Hal Barron, M.D., President of Research & Development at Calico, to its Board of Directors.“Hal is one of the most respected clinician-scientists and successful drug developers in the biotechnology ... [Published BioSpace - Oct 01 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Calico exec: Find cause before cure for age-related disorders

A top executive at Google’s antiaging biotechnology company said this week that scientists must identify and understand the underlying biology of age-related diseases like Alzheimer’s before finding a cure.A year after Google formed Calico in South San ... [Published San Francisco Chronicle - Sep 26 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 2 reports

AbbVie-partnered Calico unveils first licensing deal

Google-backed biopharma company Calico has announced its first licensing deal, securing rights to a series of compounds aimed at preventing neurodegeneration.Just a few days after announcing a , Calico has licensed a group of neuroprotective compounds ... [Published PMLive - Sep 12 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 2 reports

Google’s Calico Partners With AbbVie, Will Open R&D Facility

[ Business ]The ball is starting to get rolling with Google’s anti-aging company Calico. As reported recently , it now has a website , and today, the site added its first piece of news.Calico has partnered with AbbVie to co-invest in an R&D collaboration. ... [Published WebProNews - Sep 03 2014]

Quotes

Calico's R&D head Hal Barron said: "we look forward to working with the world-leading scientists who discovered the p7c3 class of molecules to learn whether the remarkable biological effects can be translated to the treatment of human disease."

More Content

All (8) | News (6) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Jason Rhodes joins Atlas Venture investing team [Published FierceBiotech - Oct 03 2014]
BioNews [10.1.14] [Published eClinical Trends - Oct 01 2014]
Juno Therapeutics Appoints M.D. To Board Of Di... [Published BioSpace - Oct 01 2014]
Calico exec: Find cause before cure for age-rel... [Published San Francisco Chronicle - Sep 26 2014]
AbbVie-partnered Calico unveils first licensing... [Published PMLive - Sep 12 2014]
Genentech's Former CEO and Google to Try Curing... [Published Breitbart Feed - Sep 12 2014]
Google’s Calico Partners With AbbVie, Will Open... [Published WebProNews - Sep 03 2014]
Google’s Calico Partners With AbbVie, Will Open... [Published WebProNews Feed - Sep 03 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioNews [10.1.14] [Published eClinical Trends - Oct 01 2014]
Top News HeadlineCompanyType Portola's 'breakthrough' anti-anticoagulant clears a Phase III hurdle Portola PharmaceuticalsStudy Results FDA Slaps Valeant With A Warning Letter Valeant PharmaceuticalsWarning Letter OnCore Biopharma Agrees ...
Genentech's Former CEO and Google to Try Curing... [Published Breitbart Feed - Sep 12 2014]
Calico, a company led by former Genetech CEO Art Levinson and backed by Mountain View-based Google Inc. said on September 11th that it had inked a $1.5 billion, 10-year research and commercialization deal  with AbbVie Inc. to develop treatments ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.